Latest AI and machine learning research in other cancers for healthcare professionals.
AIM: Although standardized 3D volume rendering techniques (VRT) and embolization guidance visualize and identify tumor-feeding arteries, current vessel tracking software lacks automatic angle recommendations. This forces an operator, e.g. an interventional radiologist, to leave an ongoing procedure to manually manipulate the system and find the best angle for each feeding vessel-requiring time-con...
The invasiveness prediction in renal cell carcinoma (RCC) is of significant importance for the decision of clinical surgical plans and the patients' prognosis. Currently, besides invasive pathological assessment, it mainly relies on observation through computed tomography (CT) imaging. However, limitations of human vision and qualitative descriptions restrict the accuracy of the diagnosis of renal...
Hereditary renal cell carcinoma (RCC) accounts for approximately 5-8% of all renal cancers. This review provides a comprehensive overview of the seven...
BACKGROUND: Aggressive recurrence (AR) is an important factor affecting prognosis after surgery for hepatocellular carcinoma (HCC). This study aimed t...
BACKGROUND: Reliable tools for early prediction of treatment response to androgen deprivation therapy (ADT) plus novel androgen receptor pathway inhib...
Breast cancer heterogeneity stems from diverse molecular alterations, including proteostasis loss due to chaperone system dysfunction. However, the im...
OBJECTIVE: Current systematic literature reviews largely rely on manual screening of articles retrieved through keyword search, which is time-consumin...
PURPOSE: This study aims to investigate whether a diagnostic AI model can effectively support lesion detection and staging in non-small cell lung canc...
Cancer remains one of the most biologically intricate and heterogeneous diseases, with variability spanning genetic, epigenetic, metabolic, spatial, a...
Oral cancer and its precursor lesions, known as oral potentially malignant disorders (OPMDs), present significant public health challenges due to high...
BACKGROUND: Isocitrate dehydrogenase (IDH) mutation status is an important biomarker for the diagnosis and management of nonenhancing gliomas, undersc...
OBJECTIVES: To develop and evaluate the predictive efficacy of a combined model incorporating clinical parameters and PET-based radiomics signature (R...
Circulating tumor cells are key drivers of cancer metastasis and represent powerful biomarkers for real-time monitoring of disease progression through...
Cancer is a disease that begins with genetic and epigenetic alterations occurring in specific cells, some of which can spread and migrate to other tis...
BACKGROUND & AIMS: Microvascular invasion (MVI) is a key determinant of recurrence and poor outcomes in hepatocellular carcinoma (HCC), yet accurate p...
BACKGROUND: Gastric cancer (GC) is a leading cause of global cancer mortality, characterized by aggressive progression and poor prognosis. The develop...
Lung adenocarcinoma (LUAD) is the most common histological type of lung cancer, characterized by high mortality, recurrence, and metastasis. Despite a...
The growing number of cancer cases and deaths highlights the urgent need for innovative treatment approaches. One technique that has lately been recog...
Homologous recombination deficiency (HRD) is a critical biomarker for guiding targeted therapies, yet the full range of somatic alterations driving HR...
Accurate detection of tumor boundaries is critical for the success of oncologic surgical intervention. Traditionally, palpation can handover important...